TreeWAS – Variant ID: rs28534575

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
J44.9 Chronic obstructive pulmonary disease, unspecified	0.000	0.000	1.000
J44 Other chronic obstructive pulmonary disease	0.000	0.000	1.000
J43.9 Emphysema, unspecified	0.000	0.000	1.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.000	0.000	1.000
I70-I79 Diseases of arteries, arterioles and capillaries	0.000	0.000	1.000
I71 Aortic aneurysm and dissection	0.000	0.000	1.000
J43 Emphysema	0.000	0.001	0.999
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.000	0.001	0.999
J40-J47 Chronic lower respiratory diseases	0.000	0.002	0.998
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.000	0.003	0.997
I73 Other peripheral vascular diseases	0.000	0.005	0.995
I73.9 Peripheral vascular disease, unspecified	0.000	0.009	0.991
I70 Atherosclerosis	0.000	0.016	0.984
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.000	0.023	0.977
I70.2 Atherosclerosis of arteries of the extremities	0.000	0.024	0.976
I77 Other disorders of arteries and arterioles	0.000	0.031	0.969
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.000	0.032	0.968
J42 Unspecified chronic bronchitis	0.000	0.066	0.934
I77.1 Stricture of artery	0.000	0.083	0.917
I71.3 Abdominal aortic aneurysm, ruptured	0.000	0.095	0.905
I77.9 Disorder of arteries and arterioles, unspecified	0.000	0.108	0.892
I74 Arterial embolism and thrombosis	0.000	0.118	0.882
I72 Other aneurysm	0.000	0.163	0.837
J43.2 Centrilobular emphysema	0.000	0.175	0.825
I73.0 Raynaud's syndrome	0.000	0.199	0.801
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.000	0.209	0.791
I77.0 Arteriovenous fistula, acquired	0.000	0.235	0.765
I77.2 Rupture of artery	0.000	0.235	0.765
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.264	0.736
I72.8 Aneurysm of other specified arteries	0.000	0.268	0.732
J44.8 Other specified chronic obstructive pulmonary disease	0.000	0.274	0.726
I71.8 Aortic aneurysm of unspecified site, ruptured	0.000	0.283	0.717
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.000	0.283	0.717
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.000	0.283	0.717
I71.1 Thoracic aortic aneurysm, ruptured	0.000	0.283	0.717
J43.1 Panlobular emphysema	0.000	0.284	0.716
J43.0 MacLeod's syndrome	0.000	0.284	0.716
J41 Simple and mucopurulent chronic bronchitis	0.000	0.285	0.715
I73.1 Thromboangiitis obliterans [Buerger]	0.000	0.287	0.713
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.000	0.289	0.711
I70.9 Generalised and unspecified atherosclerosis	0.000	0.294	0.705
I70.8 Atherosclerosis of other arteries	0.000	0.294	0.705
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.000	0.295	0.704
I70.0 Atherosclerosis of aorta	0.000	0.296	0.704
I74.5 Embolism and thrombosis of iliac artery	0.000	0.299	0.701
I77.5 Necrosis of artery	0.000	0.305	0.695
I77.4 Coeliac artery compression syndrome	0.000	0.305	0.695
I78 Diseases of capillaries	0.000	0.335	0.665
I72.0 Aneurysm of carotid artery	0.000	0.337	0.663
I74.8 Embolism and thrombosis of other arteries	0.000	0.339	0.661
I77.8 Other specified disorders of arteries and arterioles	0.000	0.353	0.647
J43.8 Other emphysema	0.000	0.355	0.644
I74.9 Embolism and thrombosis of unspecified artery	0.000	0.355	0.645
J40 Bronchitis, not specified as acute or chronic	0.000	0.357	0.643
I73.8 Other specified peripheral vascular diseases	0.000	0.359	0.641
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.000	0.367	0.632
I72.9 Aneurysm of unspecified site	0.000	0.373	0.627
I74.0 Embolism and thrombosis of abdominal aorta	0.000	0.394	0.606
I71.0 Dissection of aorta [any part]	0.000	0.396	0.604
I72.6 Aneurysm and dissection of vertebral artery	0.000	0.400	0.600
I72.5 Aneurysm and dissection of other precerebral arteries	0.000	0.400	0.600
I72.1 Aneurysm of artery of upper extremity	0.000	0.400	0.600
I70.1 Atherosclerosis of renal artery	0.000	0.420	0.580
I77.3 Arterial fibromuscular dysplasia	0.000	0.425	0.575
I72.4 Aneurysm of artery of lower extremity	0.000	0.428	0.572
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.000	0.428	0.571
I72.3 Aneurysm of iliac artery	0.000	0.431	0.569
I78.0 Hereditary haemorrhagic telangiectasia	0.000	0.461	0.539
I77.6 Arteritis, unspecified	0.000	0.468	0.532
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.000	0.471	0.528
J46 Status asthmaticus	0.000	0.472	0.528
I72.2 Aneurysm of renal artery	0.000	0.479	0.521
J41.8 Mixed simple and mucopurulent chronic bronchitis	0.000	0.487	0.513
J41.1 Mucopurulent chronic bronchitis	0.000	0.487	0.513
J41.0 Simple chronic bronchitis	0.000	0.487	0.513
I70.81 Atherosclerosis of other arteries (with gangrene)	0.000	0.494	0.506
I70.80 Atherosclerosis of other arteries (without gangrene)	0.000	0.494	0.506
I70.91 Generalized and unspecified atherosclerosis (with gangrene)	0.000	0.494	0.506
I70.90 Generalized and unspecified atherosclerosis (without gangrene)	0.000	0.494	0.506
I79.1 Aortitis in diseases classified elsewhere	0.000	0.495	0.505
I79.0 Aneurysm of aorta in diseases classified elsewhere	0.000	0.495	0.505
I70.01 Atherosclerosis of aorta (with gangrene)	0.000	0.495	0.505
I70.00 Atherosclerosis of aorta (without gangrene)	0.000	0.496	0.504
I78.9 Disease of capillaries, unspecified	0.000	0.523	0.477
I78.8 Other diseases of capillaries	0.000	0.534	0.466
I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.000	0.535	0.464
I70.11 Atherosclerosis of renal artery (with gangrene)	0.000	0.584	0.416
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.000	0.605	0.395
I78.1 Naevus, nonneoplastic	0.000	0.673	0.327
I70.10 Atherosclerosis of renal artery (without gangrene)	0.001	0.710	0.290
J45 Asthma	0.000	0.823	0.177
E11.3 With ophthalmic complications	0.000	0.833	0.167
E11 Non-insulin-dependent diabetes mellitus	0.000	0.835	0.165
E11.2 With renal complications	0.000	0.842	0.158
E11.5 With peripheral circulatory complications	0.000	0.844	0.156
E11.4 With neurological complications	0.000	0.854	0.146
E11.0 With coma	0.000	0.861	0.139
E11.8 With unspecified complications	0.000	0.866	0.134
J45.8 Mixed asthma	0.000	0.873	0.127
J47 Bronchiectasis	0.000	0.879	0.121
E11.7 With multiple complications	0.000	0.881	0.119
J45.1 Nonallergic asthma	0.000	0.882	0.118
E11.1 With ketoacidosis	0.000	0.886	0.114
E11.6 With other specified complications	0.000	0.887	0.112
Chapter X Diseases of the respiratory system	0.000	0.888	0.112
J90-J94 Other diseases of pleura	0.000	0.893	0.107
J92 Pleural plaque	0.000	0.896	0.104
J60-J70 Lung diseases due to external agents	0.000	0.899	0.100
J93 Pneumothorax	0.000	0.900	0.100
J92.9 Pleural plaque without asbestos	0.000	0.900	0.100
J93.1 Other spontaneous pneumothorax	0.000	0.905	0.095
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.000	0.908	0.091
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.000	0.909	0.091
J92.0 Pleural plaque with presence of asbestos	0.000	0.911	0.089
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.089	0.911	0.000
J95-J99 Other diseases of the respiratory system	0.000	0.919	0.081
J93.9 Pneumothorax, unspecified	0.000	0.919	0.081
J86 Pyothorax	0.000	0.920	0.080
J60 Coalworker's pneumoconiosis	0.000	0.920	0.080
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.079	0.921	0.000
J64 Unspecified pneumoconiosis	0.000	0.927	0.073
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours	0.000	0.928	0.072
J66 Airway disease due to specific organic dust	0.000	0.928	0.072
J63 Pneumoconiosis due to other inorganic dusts	0.000	0.928	0.072
J62 Pneumoconiosis due to dust containing silica	0.000	0.928	0.072
J65 Pneumoconiosis associated with tuberculosis	0.000	0.928	0.072
J86.9 Pyothorax without fistula	0.000	0.928	0.072
J69 Pneumonitis due to solids and liquids	0.000	0.929	0.071
J93.0 Spontaneous tension pneumothorax	0.000	0.930	0.070
J70 Respiratory conditions due to other external agents	0.000	0.931	0.069
J67 Hypersensitivity pneumonitis due to organic dust	0.000	0.931	0.068
T43.2 Other and unspecified antidepressants	0.068	0.932	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.067	0.933	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.066	0.934	0.000
E10-E14 Diabetes mellitus	0.000	0.934	0.066
J93.8 Other pneumothorax	0.000	0.935	0.065
T42.0 Hydantoin derivatives	0.064	0.936	0.000
J95 Postprocedural respiratory disorders, not elsewhere classified	0.000	0.937	0.063
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.063	0.937	0.000
E13 Other specified diabetes mellitus	0.000	0.938	0.062
J91 Pleural effusion in conditions classified elsewhere	0.000	0.938	0.062
J99 Respiratory disorders in diseases classified elsewhere	0.000	0.940	0.060
E13.9 Without complications	0.000	0.941	0.059
T42.4 Benzodiazepines	0.059	0.941	0.000
J96 Respiratory failure, not elsewhere classified	0.000	0.941	0.059
T46 Poisoning by agents primarily affecting the cardiovascular system	0.059	0.941	0.000
J86.0 Pyothorax with fistula	0.000	0.941	0.058
J94 Other pleural conditions	0.000	0.942	0.058
J85 Abscess of lung and mediastinum	0.000	0.942	0.057
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.057	0.943	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.057	0.943	0.000
T42.3 Barbiturates	0.057	0.943	0.000
T42.2 Succinimides and oxazolidinediones	0.057	0.943	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.056	0.943	0.000
N64 Other disorders of breast	0.056	0.944	0.000
J69.8 Pneumonitis due to other solids and liquids	0.000	0.944	0.056
T42.1 Iminostilbenes	0.056	0.944	0.000
N64.5 Other signs and symptoms in breast	0.055	0.945	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.055	0.945	0.000
J95.8 Other postprocedural respiratory disorders	0.000	0.945	0.055
N64.8 Other specified disorders of breast	0.055	0.945	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.053	0.947	0.000
J62.8 Pneumoconiosis due to other dust containing silica	0.000	0.948	0.052
J62.0 Pneumoconiosis due to talc dust	0.000	0.948	0.052
J63.8 Pneumoconiosis due to other specified inorganic dusts	0.000	0.948	0.052
J63.5 Stannosis	0.000	0.948	0.052
J63.4 Siderosis	0.000	0.948	0.052
J63.3 Graphite fibrosis (of lung)	0.000	0.948	0.052
J63.2 Berylliosis	0.000	0.948	0.052
J63.1 Bauxite fibrosis (of lung)	0.000	0.948	0.052
J63.0 Aluminosis (of lung)	0.000	0.948	0.052
J66.8 Airway disease due to other specific organic dusts	0.000	0.948	0.052
J66.2 Cannabinosis	0.000	0.948	0.052
J66.1 Flax-dresser's disease	0.000	0.948	0.052
J66.0 Byssinosis	0.000	0.948	0.052
J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapours	0.000	0.948	0.052
J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapours	0.000	0.948	0.052
J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapours	0.000	0.948	0.052
J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours	0.000	0.948	0.052
J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified	0.000	0.948	0.052
J68.1 Acute pulmonary oedema due to chemicals, gases, fumes and vapours	0.000	0.948	0.052
J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours	0.000	0.948	0.052
J98 Other respiratory disorders	0.000	0.948	0.052
J69.1 Pneumonitis due to oils and essences	0.000	0.949	0.051
J99.1 Respiratory disorders in other diffuse connective tissue disorders	0.000	0.949	0.050
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.050	0.950	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.050	0.950	0.000
J70.9 Respiratory conditions due to unspecified external agent	0.000	0.950	0.050
J70.8 Respiratory conditions due to other specified external agents	0.000	0.950	0.050
J70.4 Drug-induced interstitial lung disorder, unspecified	0.000	0.950	0.050
J70.3 Chronic drug-induced interstitial lung disorders	0.000	0.950	0.050
J70.2 Acute drug-induced interstitial lung disorders	0.000	0.950	0.050
J70.0 Acute pulmonary manifestations due to radiation	0.000	0.950	0.050
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.049	0.950	0.000
J67.8 Hypersensitivity pneumonitis due to other organic dusts	0.000	0.951	0.049
J67.7 Air-conditioner and humidifier lung	0.000	0.951	0.049
J67.6 Maple-bark-stripper's lung	0.000	0.951	0.049
J67.5 Mushroom-worker's lung	0.000	0.951	0.049
J67.4 Maltworker's lung	0.000	0.951	0.049
J67.3 Suberosis	0.000	0.951	0.049
J67.1 Bagassosis	0.000	0.951	0.049
J67.0 Farmer's lung	0.000	0.951	0.049
N64.9 Disorder of breast, unspecified	0.049	0.951	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.049	0.951	0.000
J67.9 Hypersensitivity pneumonitis due to unspecified organic dust	0.000	0.951	0.049
N64.4 Mastodynia	0.049	0.951	0.000
T43.9 Psychotropic drug, unspecified	0.048	0.952	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.048	0.952	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.048	0.952	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.048	0.952	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.048	0.952	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.048	0.952	0.000
E12 Malnutrition-related diabetes mellitus	0.000	0.952	0.047
T43.3 Phenothiazine antipsychotics and neuroleptics	0.047	0.953	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.047	0.953	0.000
N64.1 Fat necrosis of breast	0.047	0.953	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.047	0.953	0.000
J00-J06 Acute upper respiratory infections	0.000	0.953	0.047
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.047	0.953	0.000
J70.1 Chronic and other pulmonary manifestations due to radiation	0.000	0.954	0.046
J67.2 Bird fancier's lung	0.000	0.954	0.046
J98.9 Respiratory disorder, unspecified	0.000	0.954	0.046
J95.5 Postprocedural subglottic stenosis	0.000	0.955	0.045
J95.4 Mendelson's syndrome	0.000	0.955	0.045
J95.3 Chronic pulmonary insufficiency following surgery	0.000	0.955	0.045
J95.2 Acute pulmonary insufficiency following nonthoracic surgery	0.000	0.955	0.045
J95.1 Acute pulmonary insufficiency following thoracic surgery	0.000	0.955	0.045
T46.4 Angiotensin-converting-enzyme inhibitors	0.045	0.955	0.000
J80-J84 Other respiratory diseases principally affecting the interstitium	0.001	0.955	0.044
E13.8 With unspecified complications	0.000	0.955	0.044
E13.7 With multiple complications	0.000	0.955	0.044
E13.6 With other specified complications	0.000	0.955	0.044
E13.5 With peripheral circulatory complications	0.000	0.955	0.044
E13.4 With neurological complications	0.000	0.955	0.044
E13.3 With ophthalmic complications	0.000	0.955	0.044
E13.2 With renal complications	0.000	0.955	0.044
E13.1 With ketoacidosis	0.000	0.955	0.044
E13.0 With coma	0.000	0.955	0.044
T43.4 Butyrophenone and thioxanthene neuroleptics	0.044	0.956	0.000
T36 Poisoning by systemic antibiotics	0.044	0.956	0.000
J69.0 Pneumonitis due to food and vomit	0.000	0.956	0.044
J99.0 Rheumatoid lung disease	0.000	0.956	0.044
J85.1 Abscess of lung with pneumonia	0.000	0.956	0.043
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.043	0.957	0.000
J96.9 Respiratory failure, unspecified	0.000	0.958	0.042
J96.1 Chronic respiratory failure	0.000	0.958	0.042
J96.0 Acute respiratory failure	0.000	0.958	0.042
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.042	0.958	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.042	0.958	0.000
T46.7 Peripheral vasodilators	0.042	0.958	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.042	0.958	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.042	0.958	0.000
J94.1 Fibrothorax	0.000	0.958	0.042
J94.9 Pleural condition, unspecified	0.000	0.958	0.041
J94.0 Chylous effusion	0.000	0.958	0.041
J84 Other interstitial pulmonary diseases	0.000	0.958	0.042
J85.3 Abscess of mediastinum	0.000	0.958	0.041
J85.0 Gangrene and necrosis of lung	0.000	0.958	0.041
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.041	0.958	0.000
J95.9 Postprocedural respiratory disorder, unspecified	0.000	0.959	0.041
J94.8 Other specified pleural conditions	0.000	0.959	0.041
J98.1 Pulmonary collapse	0.000	0.959	0.041
T43.6 Psychostimulants with abuse potential	0.040	0.959	0.000
J90 Pleural effusion, not elsewhere classified	0.000	0.959	0.041
N64.3 Galactorrhoea not associated with childbirth	0.040	0.960	0.000
N64.2 Atrophy of breast	0.040	0.960	0.000
N64.0 Fissure and fistula of nipple	0.040	0.960	0.000
T38.1 Thyroid hormones and substitutes	0.040	0.960	0.000
J98.2 Interstitial emphysema	0.000	0.960	0.040
J20-J22 Other acute lower respiratory infections	0.000	0.960	0.040
J95.0 Tracheostomy malfunction	0.000	0.960	0.040
J05 Acute obstructive laryngitis [croup] and epiglottitis	0.000	0.961	0.039
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.039	0.961	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.039	0.961	0.000
T45.0 Antiallergic and antiemetic drugs	0.039	0.961	0.000
J98.4 Other disorders of lung	0.000	0.961	0.039
T47.0 Histamine H(2)-receptor antagonists	0.038	0.961	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.000	0.962	0.038
J00 Acute nasopharyngitis [common cold]	0.000	0.962	0.038
T38.9 Other and unspecified hormone antagonists	0.038	0.962	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.038	0.962	0.000
T38.7 Androgens and anabolic congeners	0.038	0.962	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.038	0.962	0.000
T38.5 Other oestrogens and progestogens	0.038	0.962	0.000
T38.4 Oral contraceptives	0.038	0.962	0.000
T38.2 Antithyroid drugs	0.038	0.962	0.000
T38.0 Glucocorticoids and synthetic analogues	0.038	0.962	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.038	0.962	0.000
J98.3 Compensatory emphysema	0.000	0.962	0.037
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.037	0.963	0.000
T40.4 Other synthetic narcotics	0.037	0.963	0.000
E14 Unspecified diabetes mellitus	0.000	0.964	0.036
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.036	0.964	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.036	0.964	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.036	0.964	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.036	0.964	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.036	0.964	0.000
T44.0 Anticholinesterase agents	0.036	0.964	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.036	0.964	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.036	0.964	0.000
T45.8 Other primarily systemic and haematological agents	0.036	0.964	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.036	0.964	0.000
T45.6 Fibrinolysis-affecting drugs	0.036	0.964	0.000
T45.4 Iron and its compounds	0.036	0.964	0.000
T45.3 Enzymes, not elsewhere classified	0.036	0.964	0.000
T45.2 Vitamins, not elsewhere classified	0.035	0.965	0.000
J45.0 Predominantly allergic asthma	0.000	0.965	0.035
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.034	0.966	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.034	0.966	0.000
T37.5 Antiviral drugs	0.034	0.966	0.000
T37.4 Anthelminthics	0.034	0.966	0.000
T37.3 Other antiprotozoal drugs	0.034	0.966	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.034	0.966	0.000
T37.1 Antimycobacterial drugs	0.034	0.966	0.000
T37.0 Sulphonamides	0.034	0.966	0.000
T41.5 Therapeutic gases	0.034	0.966	0.000
T41.4 Anaesthetic, unspecified	0.034	0.966	0.000
T41.3 Local anaesthetics	0.034	0.966	0.000
T41.2 Other and unspecified general anaesthetics	0.034	0.966	0.000
T41.1 Intravenous anaesthetics	0.034	0.966	0.000
T41.0 Inhaled anaesthetics	0.034	0.966	0.000
T49.9 Topical agent, unspecified	0.034	0.966	0.000
T49.8 Other topical agents	0.034	0.966	0.000
T49.7 Dental drugs, topically applied	0.034	0.966	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.034	0.966	0.000
T49.5 Ophthalmological drugs and preparations	0.034	0.966	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.034	0.966	0.000
T49.3 Emollients, demulcents and protectants	0.034	0.966	0.000
T49.2 Local astringents and local detergents	0.034	0.966	0.000
T49.1 Antipruritics	0.034	0.966	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.034	0.966	0.000
E12.9 Without complications	0.000	0.966	0.034
E12.8 With unspecified complications	0.000	0.966	0.034
E12.7 With multiple complications	0.000	0.966	0.034
E12.6 With other specified complications	0.000	0.966	0.034
E12.5 With peripheral circulatory complications	0.000	0.966	0.034
E12.4 With neurological complications	0.000	0.966	0.034
E12.3 With ophthalmic complications	0.000	0.966	0.034
E12.2 With renal complications	0.000	0.966	0.034
E12.1 With ketoacidosis	0.000	0.966	0.034
E12.0 With coma	0.000	0.966	0.034
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.034	0.966	0.000
T48.5 Anti-common-cold drugs	0.034	0.966	0.000
T48.4 Expectorants	0.034	0.966	0.000
T48.3 Antitussives	0.034	0.966	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.034	0.966	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.034	0.966	0.000
T48.0 Oxytocic drugs	0.034	0.966	0.000
J05.1 Acute epiglottitis	0.000	0.966	0.034
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.034	0.966	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.034	0.966	0.000
T47.7 Emetics	0.034	0.966	0.000
T47.6 Antidiarrhoeal drugs	0.034	0.966	0.000
T47.5 Digestants	0.034	0.966	0.000
T47.4 Other laxatives	0.034	0.966	0.000
T47.3 Saline and osmotic laxatives	0.034	0.966	0.000
T47.2 Stimulant laxatives	0.034	0.966	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.034	0.966	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.000	0.967	0.033
J98.0 Diseases of bronchus, not elsewhere classified	0.000	0.967	0.033
J99.8 Respiratory disorders in other diseases classified elsewhere	0.000	0.967	0.033
J98.8 Other specified respiratory disorders	0.000	0.967	0.033
E14.3 With ophthalmic complications	0.000	0.968	0.032
T36.9 Systemic antibiotic, unspecified	0.031	0.968	0.000
T36.8 Other systemic antibiotics	0.031	0.968	0.000
T36.7 Antifungal antibiotics, systemically used	0.031	0.968	0.000
T36.6 Rifamycins	0.031	0.968	0.000
T36.5 Aminoglycosides	0.031	0.968	0.000
T36.4 Tetracyclines	0.031	0.968	0.000
T36.3 Macrolides	0.031	0.968	0.000
T36.2 Chloramphenicol group	0.031	0.968	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.031	0.968	0.000
J84.8 Other specified interstitial pulmonary diseases	0.000	0.968	0.031
T40.6 Other and unspecified narcotics	0.031	0.969	0.000
T45.5 Anticoagulants	0.031	0.969	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.031	0.969	0.000
T40.8 Lysergide [LSD]	0.031	0.969	0.000
T40.7 Cannabis (derivatives)	0.031	0.969	0.000
T40.5 Cocaine	0.031	0.969	0.000
T40.3 Methadone	0.031	0.969	0.000
T40.1 Heroin	0.031	0.969	0.000
T40.0 Opium	0.031	0.969	0.000
J04 Acute laryngitis and tracheitis	0.000	0.969	0.031
J96.09 Acute respiratory failure; Type unspecified	0.000	0.969	0.030
J96.01 Acute respiratory failure; Type II [hypercapnic]	0.000	0.969	0.030
J96.00 Acute respiratory failure; Type I [hypoxic]	0.000	0.969	0.030
J96.19 Chronic respiratory failure; Type unspecified	0.000	0.969	0.030
J96.11 Chronic respiratory failure; Type II [hypercapnic]	0.000	0.969	0.030
J96.10 Chronic respiratory failure; Type I [hypoxic]	0.000	0.969	0.030
J96.99 Respiratory failure, unspecified; Type unspecified	0.000	0.969	0.030
J96.91 Respiratory failure unspecified; Type II [hypercapnic]	0.000	0.969	0.030
J96.90 Respiratory failure, unspecified; Type I [hypoxic]	0.000	0.969	0.030
J84.0 Alveolar and parietoalveolar conditions	0.000	0.970	0.030
T46.1 Calcium-channel blockers	0.029	0.971	0.000
J85.2 Abscess of lung without pneumonia	0.001	0.971	0.029
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.029	0.971	0.000
J01 Acute sinusitis	0.000	0.971	0.029
J05.0 Acute obstructive laryngitis [croup]	0.000	0.971	0.028
J20 Acute bronchitis	0.000	0.972	0.028
T36.0 Penicillins	0.027	0.972	0.000
J98.6 Disorders of diaphragm	0.000	0.972	0.027
E14.8 With unspecified complications	0.000	0.972	0.028
E14.4 With neurological complications	0.000	0.973	0.027
T50.8 Diagnostic agents	0.026	0.974	0.000
E14.7 With multiple complications	0.000	0.974	0.026
E14.0 With coma	0.000	0.974	0.026
J03 Acute tonsillitis	0.000	0.974	0.026
E14.1 With ketoacidosis	0.000	0.974	0.026
T50.7 Analeptics and opioid receptor antagonists	0.026	0.974	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.026	0.974	0.000
T50.5 Appetite depressants	0.026	0.974	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.026	0.974	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.026	0.974	0.000
T50.1 Loop [high-ceiling] diuretics	0.026	0.974	0.000
T50.0 Mineralocorticoids and their antagonists	0.026	0.974	0.000
M50.2 Other cervical disk displacement	0.000	0.974	0.026
T47.1 Other antacids and anti-gastric-secretion drugs	0.025	0.974	0.000
E21.0 Primary hyperparathyroidism	0.000	0.974	0.026
T50.4 Drugs affecting uric acid metabolism	0.025	0.975	0.000
J21 Acute bronchiolitis	0.000	0.975	0.025
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.975	0.025
M50.0 Cervical disk disorder with myelopathy	0.000	0.976	0.024
C67.2 Lateral wall of bladder	0.000	0.976	0.024
E21.3 Hyperparathyroidism, unspecified	0.000	0.976	0.024
E14.5 With peripheral circulatory complications	0.000	0.976	0.024
M50 Cervical disk disorders	0.000	0.976	0.024
J98.5 Diseases of mediastinum, not elsewhere classified	0.000	0.977	0.023
C67 Malignant neoplasm of bladder	0.000	0.977	0.023
J02 Acute pharyngitis	0.000	0.977	0.023
C67.6 Ureteric orifice	0.000	0.977	0.023
J04.1 Acute tracheitis	0.000	0.977	0.023
C67.3 Anterior wall of bladder	0.000	0.977	0.023
J94.2 Haemothorax	0.001	0.977	0.022
J04.2 Acute laryngotracheitis	0.000	0.978	0.022
J06 Acute upper respiratory infections of multiple and unspecified sites	0.000	0.978	0.022
E14.6 With other specified complications	0.000	0.978	0.022
J20.8 Acute bronchitis due to other specified organisms	0.000	0.978	0.021
J01.8 Other acute sinusitis	0.000	0.979	0.021
J01.4 Acute pansinusitis	0.000	0.979	0.021
J01.3 Acute sphenoidal sinusitis	0.000	0.979	0.021
J01.1 Acute frontal sinusitis	0.000	0.979	0.021
E14.2 Withrenal complications	0.000	0.979	0.021
J82 Pulmonary eosinophilia, not elsewhere classified	0.001	0.979	0.020
C67.1 Dome of bladder	0.000	0.979	0.021
J20.7 Acute bronchitis due to echovirus	0.000	0.979	0.020
J20.6 Acute bronchitis due to rhinovirus	0.000	0.979	0.020
J20.5 Acute bronchitis due to respiratory syncytial virus	0.000	0.979	0.020
J20.4 Acute bronchitis due to parainfluenza virus	0.000	0.979	0.020
J20.3 Acute bronchitis due to coxsackie virus	0.000	0.979	0.020
J20.2 Acute bronchitis due to streptococcus	0.000	0.979	0.020
J20.1 Acute bronchitis due to Haemophilus influenzae	0.000	0.979	0.020
J20.0 Acute bronchitis due to Mycoplasma pneumoniae	0.000	0.979	0.020
J01.0 Acute maxillary sinusitis	0.000	0.979	0.020
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.980	0.020
M50.1 Cervical disk disorder with radiculopathy	0.000	0.980	0.020
J01.9 Acute sinusitis, unspecified	0.000	0.981	0.019
Y95 Nosocomial condition	0.000	0.981	0.019
M50.9 Cervical disk disorder, unspecified	0.000	0.981	0.019
J03.8 Acute tonsillitis due to other specified organisms	0.000	0.981	0.019
J03.0 Streptococcal tonsillitis	0.000	0.981	0.019
J20.9 Acute bronchitis, unspecified	0.000	0.981	0.019
F17.1 Harmful use	0.000	0.981	0.019
J04.0 Acute laryngitis	0.000	0.982	0.018
J21.8 Acute bronchiolitis due to other specified organisms	0.000	0.982	0.018
J21.1 Acute bronchiolitis due to human metapneumovirus	0.000	0.982	0.018
J21.0 Acute bronchiolitis due to respiratory syncytial virus	0.000	0.982	0.018
J01.2 Acute ethmoidal sinusitis	0.000	0.982	0.018
C34.1 Upper lobe, bronchus or lung	0.000	0.982	0.018
E21.4 Other specified disorders of parathyroid gland	0.000	0.982	0.018
E21.2 Other hyperparathyroidism	0.000	0.982	0.018
C67.5 Bladder neck	0.000	0.982	0.018
E20-E35 Disorders of other endocrine glands	0.000	0.982	0.018
M50.8 Other cervical disk disorders	0.000	0.983	0.017
C67.7 Urachus	0.000	0.983	0.017
J02.8 Acute pharyngitis due to other specified organisms	0.000	0.983	0.017
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.983	0.017
C67.8 Overlapping lesion of bladder	0.000	0.983	0.017
E14.9 Without complications	0.000	0.983	0.017
J06.8 Other acute upper respiratory infections of multiple sites	0.000	0.984	0.016
J06.0 Acute laryngopharyngitis	0.000	0.984	0.016
J09-J18 Influenza and pneumonia	0.000	0.984	0.016
T50.9 Other and unspecified drugs, medicaments and biological substances	0.015	0.985	0.000
C67.4 Posterior wall of bladder	0.000	0.985	0.015
J02.0 Streptococcal pharyngitis	0.000	0.985	0.015
J21.9 Acute bronchiolitis, unspecified	0.000	0.985	0.014
E28 Ovarian dysfunction	0.000	0.986	0.014
E27 Other disorders of adrenal gland	0.000	0.986	0.014
E24 Cushing's syndrome	0.000	0.986	0.014
C67.0 Trigone of bladder	0.000	0.986	0.013
K70.9 Alcoholic liver disease, unspecified	0.000	0.986	0.014
E20 Hypoparathyroidism	0.000	0.987	0.013
T40.2 Other opioids	0.013	0.987	0.000
C34 Malignant neoplasm of bronchus and lung	0.000	0.987	0.013
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.987	0.013
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.987	0.013
E32 Diseases of thymus	0.000	0.987	0.013
E31 Polyglandular dysfunction	0.000	0.987	0.013
E30 Disorders of puberty, not elsewhere classified	0.000	0.987	0.013
E22 Hyperfunction of pituitary gland	0.000	0.987	0.013
F17 Mental and behavioural disorders due to use of tobacco	0.000	0.987	0.013

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations